These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25829188)

  • 21. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.
    Janssen CE; Rose CD; De Hertogh G; Martin TM; Bader Meunier B; Cimaz R; Harjacek M; Quartier P; Ten Cate R; Thomee C; Desmet VJ; Fischer A; Roskams T; Wouters CH
    J Allergy Clin Immunol; 2012 Apr; 129(4):1076-84. PubMed ID: 22464675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of gamma-hydroxybutyrate (GHB) on proinflammatory cytokine gene expression in coronary surgical procedures].
    Kleinschmidt S; Bauer M; Wanner G; Bussmann D; Ziegenfuss T; Menger MD; Larsen R
    Anaesthesist; 1998 Aug; 47(8):651-62. PubMed ID: 9770088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia.
    Maus U; Rosseau S; Knies U; Seeger W; Lohmeyer J
    Eur Respir J; 1998 Mar; 11(3):534-41. PubMed ID: 9596098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
    Davey MP; Martin TM; Planck SR; Lee J; Zamora D; Rosenbaum JT
    Microvasc Res; 2006 Mar; 71(2):103-7. PubMed ID: 16414084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
    Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
    Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.
    Yu SL; Wong CK; Wong PT; Chen DP; Szeto CC; Li EK; Tam LS
    PLoS One; 2011; 6(8):e23855. PubMed ID: 21886831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
    Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational model to analyze and characterize the functional mutations of NOD2 protein causing inflammatory disorder - Blau syndrome.
    Thirumal Kumar D; Udhaya Kumar S; Nishaat Laeeque AS; Apurva Abhay S; Bithia R; Magesh R; Kumar M; Zayed H; George Priya Doss C
    Adv Protein Chem Struct Biol; 2020; 120():379-408. PubMed ID: 32085886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
    Nakano M; Kambe N
    Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma interleukin-1beta, -6, -8 and tumor necrosis factor-alpha as highly informative markers of pelvic inflammatory disease.
    Lee SA; Tsai HT; Ou HC; Han CP; Tee YT; Chen YC; Wu MT; Chou MC; Wang PH; Yang SF
    Clin Chem Lab Med; 2008; 46(7):997-1003. PubMed ID: 18624621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
    Shikama Y; Kuroishi T; Nagai Y; Iwakura Y; Shimauchi H; Takada H; Sugawara S; Endo Y
    Innate Immun; 2011 Feb; 17(1):3-15. PubMed ID: 19897531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-exome sequencing in three children with sporadic Blau syndrome, one of them co-presenting with recurrent polyserositis.
    Córdova-Fletes C; Rangel-Sosa MM; Martínez-Jacobo LA; Becerra-Solano LE; Arellano-Valdés CA; Tlacuilo-Parra JA; Galán-Huerta KA; Rivas-Estilla AM; Hernandez-Orozco AA; García-Ortiz JE
    Autoimmunity; 2020 Sep; 53(6):344-352. PubMed ID: 32597225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blau syndrome with a rare mutation in exon 9 of
    Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
    Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blau syndrome-associated uveitis and the NOD2 gene.
    Pillai P; Sobrin L
    Semin Ophthalmol; 2013; 28(5-6):327-32. PubMed ID: 24010719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls.
    Mohamed MA; Cunningham-Rundles S; Dean CR; Hammad TA; Nesin M
    Cytokine; 2007 Sep; 39(3):171-7. PubMed ID: 17884557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial Blau syndrome without uveitis caused by a novel mutation in the nucleotide-binding oligomerization domain-containing protein 2 gene with good response to infliximab.
    Toral-López J; González-Huerta LM; Martín-Del Campo M; Messina-Baas O; Cuevas-Covarrubias SA
    Pediatr Dermatol; 2018 May; 35(3):e180-e183. PubMed ID: 29570830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the molecular basis of the NOD2 signalling pathway.
    Boyle JP; Parkhouse R; Monie TP
    Open Biol; 2014 Dec; 4(12):. PubMed ID: 25520185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blau syndrome associated with a CARD15/NOD2 mutation.
    Snyers B; Dahan K
    Am J Ophthalmol; 2006 Dec; 142(6):1089-92. PubMed ID: 17157607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial case of Blau syndrome associated with a CARD15/NOD2 mutation.
    Villanueva-Mendoza C; Arellanes-García L; Cubas-Lorenzo V; Jimenez-Martinez MC; Flores-Suárez LF; Zenteno JC
    Ophthalmic Genet; 2010 Sep; 31(3):155-8. PubMed ID: 20565245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.